University of California17h
Breathing new life: Working toward an inhalable gene therapy for cystic fibrosis
Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...
Cystic Fibrosis Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
In March 2025, Vertex Pharmaceuticals Incorporated announced a study is to evaluate the safety, and tolerability and efficacy ...
NHS hope as new miracle drug greatly reduces some cystic fibrosis symptoms
The genetic condition cystic fibrosis had no treatments on the NHS before 2019 and a Daily Express campaign - now a miracle ...
Medscape2d
Racial Disparities Widen in Modern Cystic Fibrosis Care
Among the candidates listed for lung transplant, those with an indication of CF decreased from 13.3% in the pre–highly ...
Cystic Fibrosis Foundation23h
Cystic Fibrosis Foundation Celebrates New National Volunteer Advocacy Co-Chairs
The Foundation’s National Volunteer Advocacy Committee provides guidance and support to further strengthen and enhance the ...
Cystic fibrosis patients could get new 'once-a-day' pill this year
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
UnitedHealth eases rules on renewing some prescription drugs
UnitedHealth Group's pharmacy benefit manager, Optum Rx, said on Wednesday it would ease requirements to get insurance ...
Science Daily5d
Newly uncovered mechanism could drive next-gen cystic fibrosis treatments
The Hospital for Sick Children. "Newly uncovered mechanism could drive next-gen cystic fibrosis treatments." ScienceDaily. ScienceDaily, 13 March 2025. <www.sciencedaily.com / releases / 2025 / 03 / ...
Insmed price target raised to $96 from $92 at BofA
BofA analyst Jason Zemansky raised the firm’s price target on Insmed (INSM) to $96 from $92 and keeps a Buy rating on the shares. The firm’s ...